The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksINS.L Regulatory News (INS)

  • There is currently no data for INS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Instem plc

17 Nov 2023 12:00

RNS Number : 8352T
Stifel Nicolaus Europe Limited
17 November 2023

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Name of exempt principal trader:

Stifel Nicolaus Europe Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Instem plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Instem plc

(d) Date dealing undertaken:

16 November 2023

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary

Buy

200

828.25 GBX

828.25 GBX

Ordinary

Sell

5,000

830 GBX

830 GBX

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

Date of disclosure:

17 November 2023

Contact name:

Joseph Hamshare

Telephone number:

0203 465 1195

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
FERBRBLTMTBBMMJ
Date   Source Headline
29th May 20137:00 amRNSGlobal R&D Organisation selects Centrus & SRS
23rd May 20133:08 pmRNSResult of AGM
13th May 20137:00 amRNSAcquisition of Logos Technologies
26th Apr 20134:48 pmRNSPosting of Annual Report, Notice of AGM
23rd Apr 20136:20 pmRNSHolding(s) in Company
18th Apr 20137:00 amRNSCustomer Wins for New Provantis Release
27th Mar 20137:00 amRNSFinal Results
12th Mar 20137:00 amRNSNotice of Final Results
1st Mar 20133:25 pmRNSHolding(s) in Company
28th Feb 20137:00 amRNSUS Government Contract Win
30th Jan 20139:42 amRNSHolding(s) in Company
21st Jan 20137:00 amRNSHolding(s) in Company
10th Jan 20137:01 amRNSJOINN Laboratories China Purchases Provantis
10th Jan 20137:00 amRNSTrading Update
24th Dec 20127:00 amRNSTrading Update
18th Dec 20127:00 amRNSMulti-year Contract Extension & New Awards
3rd Dec 20127:00 amRNSCentrus Contract Win
7th Nov 20127:00 amRNSContract Win with US Government Research Agency
29th Oct 20127:00 amRNSChange of name of Nominated Adviser and Broker
19th Sep 20127:00 amRNSUnaudited Interim Results
5th Sep 20127:00 amRNSNotice of Interim Results
26th Jul 20127:00 amRNSTrading Update
25th Jul 20125:40 pmRNSHolding(s) in Company
22nd May 20123:46 pmRNSResult of AGM
8th May 201212:11 pmRNSPosting of Annual Report, Notice of AGM
24th Apr 20129:17 amRNSHolding(s) in Company
30th Mar 20124:52 pmRNSTotal Voting Rights and Capital
29th Mar 20122:49 pmRNSHolding(s) in Company
28th Mar 20127:00 amRNSFinal Results
26th Mar 20127:00 amRNSEstablishment of Instem India
8th Mar 20127:00 amRNSIssue of Equity and Director/PDMR Shareholding
20th Feb 20127:00 amRNSNotice of Final Results
9th Feb 20128:34 amRNSDirector/PDMR Shareholding
1st Feb 20129:14 amRNSAppointment of Nominated Adviser and Broker
18th Jan 20126:21 pmRNSChange of Name
9th Jan 20127:00 amRNSTrading Update
30th Nov 20113:57 pmRNSAppointment of CFO
21st Sep 20117:00 amRNSUnaudited Interim Results
10th Aug 20112:57 pmRNSNotification of Death of Director
4th May 20115:32 pmRNSPosting of Annual Report & Notice of AGM
22nd Mar 20117:00 amRNSFinal Results
4th Mar 20117:00 amRNSAcquisition of BioWisdom
19th Jan 20117:00 amRNSTrading Update
29th Oct 201011:34 amRNSTotal Voting Rights
19th Oct 20107:00 amRNSHolding(s) in Company
15th Oct 201010:38 amRNSHolding(s) in Company
13th Oct 20107:00 amRNSFirst Day of Dealings on AIM
19th Feb 20083:38 pmRNSDividend Declaration
15th Feb 200811:34 amRNSResults of GM
31st Jan 20083:28 pmRNSNotification of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.